Expression of mutated hepatitis B virus X genes in human hepatocellular carcinomas

International Journal of Cancer

Volumn 80, Issue 4, 1999, Pages 497-505

  Poussin, Karine ^a   Dienes, Hans ^b   Sirma, Hüseyin ^a   Urban, Stefan ^c   Beaugrand, Michel ^d   Franco, Dominique ^e   Schirmacher, Peter ^f   Bréchot, Christian ^a,g   Bréchot, Patricia Paterlini ^a  

^a INSERM   (France)

^b UNIVERSITY OF COLOGNE   (Germany)

^c UNIVERSITY OF HEIDELBERG   (Germany)

^d HÔPITAL JEAN VERDIER   (France)

^e HÔPITAL ANTOINE BÉCLÈRE   (France)

^f UNIVERSITY MEDICAL CENTER MAINZ   (Germany)

^g HÔPITAL NECKER ENFANTS MALADES   (France)

Author keywords

[No Author keywords available]

Indexed keywords

HEPATITIS B SURFACE ANTIGEN; MUTANT PROTEIN; VIRUS DNA; VIRUS PROTEIN; VIRUS RNA;

ADOLESCENT; ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; DNA SEQUENCE; FEMALE; FRAMESHIFT MUTATION; GENE EXPRESSION; HEPATITIS B VIRUS; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOBLOTTING; IMMUNOFLUORESCENCE; IMMUNOHISTOCHEMISTRY; LIVER CARCINOGENESIS; LIVER CELL CARCINOMA; MALE; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

EID: 0033521846     PISSN: 00207136     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1097-0215(19990209)80:4<497::AID-IJC3>3.0.CO;2-8     Document Type: Article

References (49)

1. ARH, M., TAKADA, S. and KOIKe, K., Identification of three essential regions of hepatitis B virus X protein for trans-activation function. Oncogene, 7, 397-403 (1992).
2. BENN, J. and SCHNEIDER, R., Hepatitis B virus HBx protein deregulates cell cycle checkpoint controls. Proc. nat. Acad. Sci. (Wash.), 92, 11215-11219 (1995).
3. CHIRILLO, P., PAGANO, S., NATOLI, G., PURI, P., BURGIO, V., BALSANO, C. and LEVRERO, M., The hepatitis B virus X gene induces p53-mediated programmed cell death. Proc. nat. Acad. Sci. (Wash.), 94, 8162-8167 (1997).
4. DANDRI, M., SCHIRMACHER, P. and ROGLER, C., Woodchuck hepatitis virus X protein is present in chronically infected woodchuck liver and woodchuck hepatocellular carcinomas which are permissive for viral replication. J. Virol., 70, 5246-5254 (1996).
5. DIAMANTIS, I.D., MCGANDY, C.E., CHEN, T.-J., LIAW, Y.-F., GUDAT, F. and BIANCHI, L., Hepatitis B X-gene expression in hepatocellular carcinoma. J. Hepatol., 15, 400-403 (1992).
6. FEITELSON, M., DUAN, L., GUO, J. and BLUMBERG, B., X region deletion mutants associated with surface antigen-positive hepatitis B virus infections. Gastroenterology, 108, 1810-1819 (1995).
7. FUKUDA, R., XUAN-THAN, N., ISHIMURA, N., ISHIHARA, S., CHOWDHURY, A., KOHGE, N., AKAGI, S., WATANABE, M. and FUKUMOTO, S., X gene and precore region mutants in the hepatitis B virus genome in persons positive for antibody to hepatitis B e antigen: comparison between asymptomatic "healthy" carriers and patients with severe chronic active hepatitis. J. infect. Dis., 172, 1191-1197 (1995).
8. GERKEN, G., PATERLINI, P., MANNS, M., HOUSSET, C. TERRE, S., DIENES, H.P., HESS, G., GERLICH, W.H., BERTHELOT, P., MEYER ZUM BÜSCHENFELDE, K.H. and BRÉCHOT, C., Assay of hepatitis B virus DNA by polymerase chain reaction and its relationship to pre-S and S-encoded viral surface antigens. Hepatology, 13, 158-166 (1991).
9. GOTOH, K., MIMA, S., UCHIDA, T., SHIKATA, T., YOSHIZAWA, K., IRIE, M. and MIZUI, M., Nucleotide sequence of hepatitis B virus isolated from subjects without serum anti-hepatitis B core antibody. J. med. Virol., 46, 201-206 (1995).
10. HENKLER, F., WASEEM, N., GOLDING, M., ALISON, M. and KOSHY, R., Mutant p53 but not hepatitis B virus X protein is present in hepatitis B virus related human hepatocellular carcinoma. Cancer Res., 55, 6084-6091 (1995).
11. HORIKITA, M., ITOH, S., YAMAMOTO, K., SHIBAYAMA, T., TSUDA, F. and OKAMOTO, H., Differences in the entire nucleotide sequence between hepatitis B virus genomes from carriers positive for antibody to hepatitis B e antigen with and without active disease. J. med. Virol, 44, 96-103 (1994).
12. HSIA, C., NAKASHIMA, Y. and TABOR, E., Deletion mutants of the hepatitis B virus X gene in human hepatocellular carcinoma. Biochem. biophys. Res. Comm., 241, 726-729 (1998).
13. JACOB, J., ASCENZI, M., RONEKER, C., TOSHKOV, I., COTE, P.G., JR. and TENNANT, B., Hepatic expression of the woodchuck hepatitis virus X-antigen during acute and chronic infection and detection of a woodchuck hepatitis X-antigen antibody response. Hepatology, 26, 1607-1615 (1997).
14. KASEKO, M., UCHIDA, T., MORIYAMA, M., ARAKAWA, Y., SHIKATA, T., GOTOH, K. and MIMA, S., Probable implication of mutations of the X open reading frame in the onset of fulminant hepatitis B. J. med. Virol., 47, 204-208 (1995).
15. KATAYAMA, K., HAYASHI, N., SASAKI, Y., KASAHARA, A., UEDA, K., FUSAMOTO, H., SATO, N., CHISAKA, O., MATSUBARA, K. and KAMADA, T., Detection of hepatitis B virus X gene protein and antibody in type B chronic liver disease. Gastroenterology, 97, 990-998 (1989).
16. KEKULÉ, A., Hepatitis B virus transactivator proteins: the "trans" hypothesis of liver carcinogenesis. In C. Bréchot (ed.). Primary liver cancer: etiological and progression factors, pp. 191-210, CRC Press, London (1994).
17. KIDD-LJUNGGREN, K., OBERG, M. and KIDD, A., The hepatitis B virus X gene: analysis of functional domain variation and gene phylogeny using multiple sequences. J. gen. Virol., 76, 2119-2130 (1995).
18. KOIKE, K., MORIYA, K., IIONO, S., YOTSUYANAGI, H., ENDO, Y., MIYAMURA. T. and KUROKAWA, K., High level expression of hepatitis B virus HBx gene and hepatocarcinogenesis in transgenic mice. Hepatology, 19, 810-819 (1994a).
19. KOIKE, K., MORIYA, H., YOTSUYANAGI, H., IINO, S. and KUROKAWA, K., Induction of cell cycle progression by hepatitis B virus HBx gene expression in quiescent mouse fibroblasts. J. clin. Invest., 94, 44-49 (1994b).
20. KOIKE, K. and TAKADA, S., Biochemistry and functions of hepatitis B virus X protein. Intervirology, 38, 89-99 (1995).
21. KUMAR, V., NARAYANA, J. and KUMAR, R., A truncated mutant (residues 58-140) of the hepatitis B virus X protein retains transactivation function. Proc. nat. Acad. Sci. (Wash.), 93, 5647-5652 (1996).
22. LEE, T., FIKEGOLD, M., SHEN, R., DEMAYO, J., WOO, S. and BUTEL, J., Hepatitis B virus transactivator X protein is not tumorigenic in transgenic mice. J. Virol., 64, 5939-5947 (1990).
23. LIANG, T., BLUM, H. and WANDS, J., Characterization and biological properties of a hepatitis B virus isolated from a patient without hepatitis B virus serologic markers. Hepatology, 12, 204-212 (1990).
24. LUBER, B., ARNOLD, N., STURZL, M., HOHNE, M., SCHIRMACHER, P., LAUER, U., WIENBERG, J., HOFSCHNEIDER, P. and KEKULÉ, A., Hepatoma derived integrated HBV DNA causes multi-stage transformation in vitro. Oncogene, 12, 1597-1608 (1996).
25. MILLER, R., Evolutionary relationship between hepadnavirus and retroviruses. In L. McLachlan (ed.), Molecular biology of hepatitis B virus, pp. 227-244, CRC Press, Boca Raton, FL (1991).
26. MILLER, R.H. and ROBINSON, W.S., Common evolutionary origin of hepatitis B virus and retroviruses. Proc. nat. Acad. Sci. (Wash.), 83, 2531-2535 (1986).
27. MINAMI, M., POUSSIN, K., KEW, M., OKANOUE, T., BRÉCHOT, C. and PATERLINI, P., Precore/core mutations of hepatitis B virus in hepatocellular carcinomas developed on noncirrhotic livers. Gastroenterology, 111, 691-700 (1996).
28. MIYAKI, M., SATO, C., GOTANDA, T., MATSUI, S., IMAI, M. and MAYUMI, M., Integration of region X of hepatitis B virus genome in human primary hepatocellular carcinomas propagated in nude mice. J. gen. Virol., 67, 1449-1454 (1986).
29. OKAMOTO, H., TSUDA, F., SAKUGAWA, H., SASTROEWIGUGO, R., IMAI, M., MIYAKAWA, Y. and MAYUMI, M., Typing hepatitis B virus by homology in nucleotidic sequence: comparison of surface antigen subtypes. J. gen. Virol., 69, 2575-2583 (1988).
30. ORITO, E., MIZOKAMI, M., INA, Y., MORIYAMA, E., KAMESHIMA, N., YAMAMOTO, M. and GOJOBORI, T., Host-independent evolution and a genetic classification of the hepadnavirus family based on nucleotide sequences. Proc. nat. Acad. Sci. (Wash.), 86, 7059-7062 (1989).
31. PATERLINI, P. and BRÉCHOT, C. Hepatitis B virus and primary liver cancer in hepatitis B surface antigen-positive and -negative patients. In C. Bréchot (ed.), Primary liver cancer: etiological and progression factors, pp. 167-190, CRC Press, London (1994).
32. PATERLINI, P., POUSSIN, K., KEW, M., FRANCO, D. and BRÉCHOT, C., Selective accumulation of the X transcript of hepatitis B virus in patients negative for hepatitis B surface antigen with hepatocellular carcinoma. Hepotology, 21, 313-321 (1995).
33. PREISLER ADAMS, S., SCHLAYER, H., PETERS, T., HETTLER, F., GEROK, W. and RASENACK, J., Sequence analysis of hepatitis B virus DNA in immunologically negative infection. Arch. Virol., 133, 385-396 (1993).
34. REPP, R., KELLER, C., BORKHARDT, A., CSECKE, A., SCHAFER, S. and GERLICH, W., Detection of a hepatitis B virus variant with a truncated X gene and enhancer II. Arch. Virol., 125, 299-304 (1992).
35. SCHLUTER, V., MEYER, M. and HOFSCHNEIDER, P., Integrated hepatitis B virus X and 3′ truncated preS/S sequences derived from human hepatomas encode functionally active transactivalors. Oncogene, 9, 1-10 (1994).
36. SIRMA, H., ROSMORDUC, O., URBAN, S., KREMSDORF, D. and BRÉCHOT, C., Cytoplasm is the prime location of hepatitis B virus X protein where it targets proteasomes/subunits. In M. Rizzetto (ed.), IX. Triennal international symposium on viral hepatitis and liver diseases, pp. 15-19, CpA, Rome (1996).
37. SLAGLE, B., LEE, T., MEDINA, D., FINEGOLD, M. and BUTEL, J., Increased sensitivity to the hepatocarcinogen diethylnitrosamine in transgenic mice carrying the hepatitis B virus X gene. Mol. Carcinocenesis, 15, 261-269 (1996).
38. SU, Q., SCHRODER, C., HOFMANN, W., OTTO, G., PICHLMAYR, R. and BANNACH, P., Expression of hepatitis B virus X protein in HBV-infected human livers and hepatocellular carcinomas. Hepatology, 27, 1109-1120 (1998).
39. TAKADA, S., KIDO, H., FUKUTOMI, A., MORI, T. and KOIKE, K., Interaction of hepatitis B virus X protein with a serine protease, tryptase TL2, as an inhibitor. Oncogene, 9, 341-348 (1994).
40. TAKADA, S. and KOIKE, K., Trans-activation function of a 3′ truncated X gene-cell fusion product from integrated hepatitis B virus DNA in chronic hepatitis tissues. Proc. nat. Acad. Sci. (Wash.), 87, 5628-5632 (1990).
41. TAKADA, S. and KOIKE, K., Three sites of the hepatitis B virus X protein cooperatively interact with cellular proteins. Virology, 205, 503-510 (1994).
42. TERRADILLOS, O., BILLET, O., RENARD, C., LEVY, R., MOLINA, T., BRIAND, P. and BUENDIA, M., The hepatitis B virus X gene potentiates c-myc induced liver oncogenesis in transgenic mice. Oncogene, 14, 395-404 (1997).
43. UCHIDA. T., GOTOCH, K. and SHIKATA, T., Complete nucleotide sequences and the characteristics of two hepatitis B virus mutants causing serologically negative acute or chronic hepatitis B. J. med. Virol., 45, 247-252 (1995).
44. UNSAL, H., YAKICIER, C., MARÇAIS, C., KEW, M., VOLKMANN, M., ZENTGRAF, H., ISSELBACHER, K.J. and OZTURK, M., Genetic heterogeneity of hepatocellular carcinoma. Proc. nat. Acad. Sci. (Wash.), 91, 822-826 (1994).
45. URASHIMA, T., SAIGO, K., KOBAYASHI, S., IMASEKI, H., KONDO, Y., KOIKE, K. and ISONO, K., Identification of hepatitis B virus integration in hepatitis C virus-infected hepatocellular carcinoma tissues. J. Hepatol., 26, 771-778 (1997).
46. URBAN, S., HILDT, E., ECKERSKORN, C., SIRMA, H., KEKULÉ, A. and HOFSCHNEIDER, P., Isolation and molecular characterization of hepatitis B virus X-protein from a baculovirus expression system. Hepatology, 26, 1045-1053 (1997).
47. VITVITSKI-TREPO, L., KAY, A., PICHOUD, C., CHEVALLIER, P., DE-DINECHIN, S., SHAMOON, B.M., MANDART, E., TREPO, C. and GALIBERT, F., Early and frequent detection of HBxAg and/or anti-HBxAg in hepatitis B virus infection. Hepatology, 12, 1278-1283 (1990).
48. WANG, W., LONDON, T. and FEITELSON, M., Hepatitis B X antigen in hepatitis B virus carrier patients with liver cancer. Cancer Res., 51, 4971-4977 (1991).
49. ZHU, M., LONDON, W., DUAN, L.-X. and FEITELSON, M., The value of hepatitis B X antigen as prognostic marker in the development of hepatocellular carcinoma. Int. J. Cancer, 55, 571-576 (1993).